Scientists Discover Why Some Pancreatic Tumors Resist Immune System Attacks
New research reveals how cancer cells block immune-fighting structures, opening doors to better pancreatic cancer treatments.
396 articles in this topic
New research reveals how cancer cells block immune-fighting structures, opening doors to better pancreatic cancer treatments.
New framework reveals why immune cells fail to control tumors in metabolically active tissues, opening paths for better treatments.
New research reveals how liver cancer develops, identifying immune-quiet and inflamed pathways that could enable early intervention.
Analysis of 50,000+ tumors shows one-third of cancer drivers behave differently than expected, with major implications for treatment.
Liquid biopsy with next-generation sequencing shows promise for predicting glioma patient outcomes through circulating tumor DNA analysis.
New liquid biopsy technology identifies actionable cancer mutations in blood, enabling earlier detection and personalized treatment monitoring.
Breakthrough biosensors analyze blood and other fluids to detect cancer biomarkers, offering faster, less invasive diagnosis than traditional methods.
Surface proteins on tiny cellular packages could revolutionize early breast cancer detection through simple blood tests.
Comprehensive review reveals surgical and emerging biomarker approaches that significantly reduce cancer risk for women with Lynch syndrome.
Researchers are developing advanced liquid biopsies using AI to catch cancer early and monitor treatment response.
Liquid biopsies using circulating tumor DNA and cells may revolutionize early detection of breast cancer metastasis risk.
New CRISPR-based diagnostic tools could detect cancer biomarkers more accurately and affordably than current methods.